From 2,000+ patients · Aetna is already seeing results
Aetna coverage for FDA-approved brand-name GLP-1 medications varies by plan and state. Many plans require prior authorization and BMI documentation. Weight Method offers compounded semaglutide and tirzepatide programs from $199/month as a cash-pay pathway separate from insurance, with licensed providers and direct shipping. Compounded medications are not FDA-approved.
Coverage Details
Aetna typically requires prior authorization for both Wegovy (semaglutide) and Zepbound (tirzepatide) for weight management. Common requirements include a documented BMI of 30+ (or 27+ with comorbidities), evidence of failed diet and exercise programs lasting 3-6 months, and sometimes proof that other weight loss medications were tried first. Even when approved, many Aetna plans impose step therapy requirements, quantity limits, and specialty pharmacy mandates. Copays for covered members can still range from $50-$300 per month depending on the plan tier.
Affordable Alternative
Weight Method offers a straightforward alternative to navigating Aetna's coverage maze. At $154/month for semaglutide and $329/month for tirzepatide, you skip the prior authorization process entirely, start treatment within days, and pay a predictable monthly rate. There are no surprise copays, no pharmacy denials, and no coverage gaps if you change jobs or plans.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.
